Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06244199 · ClinicalTrials.gov registry record · NA
Transition to Cardiac Rehabilitation (T2CR) to Address Barriers of Multimorbidity and Frailty
A NA study of Cardiovascular Diseases and Cardiac Rehabilitation, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 2
- Study locations
NCT06244199 is a NA study of Cardiovascular Diseases and Cardiac Rehabilitation that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 250 participants, below the 26,973-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT06244199, a NA study of Cardiovascular Diseases and Cardiac Rehabilitation, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 2
- Study locations
Study Summary
Cardiac rehabilitation (CR) is a secondary prevention program for patients with cardiovascular disease (CVD). It is especially valuable as CVD increasingly occurs in combination with comorbidity, frailty, and complexities of care that predispose patients to functional decline, disability, and high costs. Still, few Veterans participate in CR, in part because of the difficult logistics to attend. Promising Practice home-based CR (HBCR) was developed to increase CR participation, but many Veterans remain too limited by comorbidity and frailty for participation. A Transition to CR (T2CR) intervention is a face-to-face program that fosters vital skills, education, insights, motivation, and patient-provider relationships conducive to successful HBCR thereafter. This study compares Veterans eligible for CR who are randomized to T2CR intervention versus usual care. Differences in functional capacity, HBCR participation, and healthy days at home are compared over one year. Patients' experiences and providers' perspectives of barriers and facilitators to T2CR are also compared.
Conditions Studied
Interventions
- OTHER Usual Care
- BEHAVIORAL T2CR Intervention
Study Locations (2)
Massachusetts
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA - Boston
Pennsylvania
- VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2024-11-01 |
| Est. Completion | 2027-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06244199
The ClinicalTrials.gov registry entry for NCT06244199 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,973-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT06244199 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06244199 about?
NCT06244199 is a clinical study titled "Transition to Cardiac Rehabilitation (T2CR) to Address Barriers of Multimorbidity and Frailty". Cardiac rehabilitation (CR) is a secondary prevention program for patients with cardiovascular disease (CVD). It is especially valuable as CVD increasingly occurs in combination with comorbidity, frailty, and complexities of care that predispose patients to functional decline, disability, and high c...
What is the current status of trial NCT06244199?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2024-11-01. Estimated completion is 2027-08-31.
What conditions does trial NCT06244199 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Cardiac Rehabilitation, Transition of Care.
What interventions are being tested in trial NCT06244199?
The interventions under investigation include: Usual Care (OTHER), T2CR Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06244199?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06244199 being conducted?
This trial has 2 study locations across Massachusetts, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.